Please login to the form below

Not currently logged in
Email:
Password:

Rubius Therapeutics

This page shows the latest Rubius Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Rubius Therapeutics poaches Novartis’ Spencer Fisk

Rubius Therapeutics poaches Novartis’ Spencer Fisk

Rubius Therapeutics poaches Novartis’ Spencer Fisk. He joins the US biotech as its senior VP manufacturing. ... Novartis’former vice president and global head of cell and gene technical development and manufacturing Spencer Fisk has decided to join

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Rubius Therapeutics adds to its board of directors Rubius Therapeutics adds to its board of directors

    Rubius Therapeutics adds to its board of directors. Francis Cuss and Catherine Sohn join the US biotech. ... US biotech Rubius Therapeutics has made two appointments to its board of directors with the addition of Francis Cuss and Catherine Sohn (pictured)

  • Rubius Therapeutics strengthens senior team Rubius Therapeutics strengthens senior team

    Rubius Therapeutics strengthens senior team. Four new hires join the US-based company. ... Rubius Therapeutics, a company focused on creating Red-Cell Therapeutics, has bolstered its senior team with the addition of four new hires.

  • David Epstein joins Flagship Pioneering as executive partner David Epstein joins Flagship Pioneering as executive partner

    In this newly-created position, Epstein will begin working with Rubius Therapeutics, a red blood cell-focused exploratory venture within the Flagship portfolio, as chairman of its board.

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
wethepeople

wethepeople are bringing human appeal back to brand communications. Our approach allows us to create strategies, ideas and experiences that...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics